Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

25.34
-6.0900-19.38%
Post-market: 24.92-0.4200-1.66%19:57 EDT
Volume:246.48K
Turnover:6.65M
Market Cap:42.28M
PE:- -
High:31.43
Open:29.49
Low:25.22
Close:31.43
52wk High:152.22
52wk Low:11.52
Shares:1.67M
Float Shares:1.67M
Volume Ratio:0.73
T/O Rate:14.77%
Dividend:3.85
Dividend Rate:15.19%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus AI says multi-center study validates FDA-cleared ECG model predicting 1-year atrial fibrillation risk

Reuters
·
Jun 11

Tempus unit Ambry study finds ExomeReveal RNA testing boosts clarity for uncertain exome results

Reuters
·
Jun 09

If AI Healthcare Wins Big These Three Stocks Could Matter

Simply Wall St.
·
Jun 08

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Is Tempus AI’s (TEM) New Oncology Tools Quietly Redefining Its Precision Medicine Moat?

Simply Wall St.
·
Jun 06

Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350

Reuters
·
Jun 04

Tempus AI launches open-source digital pathology consortium

TIPRANKS
·
Jun 03

Tempus AI assumed with a Peer Perform at Wolfe Research

TIPRANKS
·
Jun 02

Tempus AI announced the upcoming clinical availability of xH

TIPRANKS
·
Jun 01

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh

THOMSON REUTERS
·
Jun 01

Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Tempus AI Price Target Maintained With a $80.00/Share by BTIG

Dow Jones
·
Jun 01

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)

TIPRANKS
·
Jun 01

Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development

MT Newswires Live
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Short Report: Tempus AI short interest at record high

TIPRANKS
·
Jun 01

Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs

TIPRANKS
·
May 31

Tempus AI announces introduction of Tempus Preview

TIPRANKS
·
May 31

Tempus AI CEO and Chairman Eric Lefkofsky reports sale of 166,250 common shares worth $7.76 million

Reuters
·
May 30

AI Application Software Shares Extended Gains. Palantir Up 10%; Salesforce And Rubrik Up 8%; Snowflake, GitLab And HubSpot Up 6%

Tiger Newspress
·
May 29